Style | Citing Format |
---|---|
MLA | Abdolmohammadivahid S, et al.. "Anti-Thyroid Antibodies and Underlying Generalized Immunologic Aberrations in Patients With Reproductive Failures." Journal of Reproductive Immunology, vol. 154, no. , 2022, pp. -. |
APA | Abdolmohammadivahid S, Samaie V, Hashemi H, Mehdizadeh A, Dolati S, Ghodratikhakestar F, Niafar M, Yousefi M (2022). Anti-Thyroid Antibodies and Underlying Generalized Immunologic Aberrations in Patients With Reproductive Failures. Journal of Reproductive Immunology, 154(), -. |
Chicago | Abdolmohammadivahid S, Samaie V, Hashemi H, Mehdizadeh A, Dolati S, Ghodratikhakestar F, Niafar M, Yousefi M. "Anti-Thyroid Antibodies and Underlying Generalized Immunologic Aberrations in Patients With Reproductive Failures." Journal of Reproductive Immunology 154, no. (2022): -. |
Harvard | Abdolmohammadivahid S et al. (2022) 'Anti-Thyroid Antibodies and Underlying Generalized Immunologic Aberrations in Patients With Reproductive Failures', Journal of Reproductive Immunology, 154(), pp. -. |
Vancouver | Abdolmohammadivahid S, Samaie V, Hashemi H, Mehdizadeh A, Dolati S, Ghodratikhakestar F, et al.. Anti-Thyroid Antibodies and Underlying Generalized Immunologic Aberrations in Patients With Reproductive Failures. Journal of Reproductive Immunology. 2022;154():-. |
BibTex | @article{ author = {Abdolmohammadivahid S and Samaie V and Hashemi H and Mehdizadeh A and Dolati S and Ghodratikhakestar F and Niafar M and Yousefi M}, title = {Anti-Thyroid Antibodies and Underlying Generalized Immunologic Aberrations in Patients With Reproductive Failures}, journal = {Journal of Reproductive Immunology}, volume = {154}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Abdolmohammadivahid S AU - Samaie V AU - Hashemi H AU - Mehdizadeh A AU - Dolati S AU - Ghodratikhakestar F AU - Niafar M AU - Yousefi M TI - Anti-Thyroid Antibodies and Underlying Generalized Immunologic Aberrations in Patients With Reproductive Failures JO - Journal of Reproductive Immunology VL - 154 IS - SP - EP - PY - 2022 ER - |